Latest New Zealand News

Page 8 of 275
Activeport’s Q1 FY27 revenue rose 18% to A$1.72 million as software sales more than doubled, while a completed restructure promises A$2 million in annualised savings. The sharper growth story arrives with a pressing funding question: quarter-end cash covered only 0.7 quarters of reported operating outflows.
Sophie Babbage
Sophie Babbage
30 Oct 2026
Vita Resources ended the September quarter with just A$77,000 in cash, equivalent to an estimated 0.2 quarters of funding, even as it expands Ninnis exploration and pursues new gold opportunities in New Zealand. The company is seeking up to A$500,000 through a non-underwritten share purchase plan while key exploration milestones remain ahead.
Victor Sage
Victor Sage
30 Oct 2026
EZZ Life Science cut its quarterly operating cash outflow sharply despite a 37.7% drop in customer receipts, as weaker Chinese e-commerce sales continued to weigh. EAORON skincare growth and a $9.16 million cash balance offer some support, but distributor collections and potential product returns remain unresolved.
Victor Sage
Victor Sage
30 Oct 2026
RocketBoots has begun installing its global retail contract in US stores and received its first payment, but quarterly operating cash outflows of A$1.75 million left the company with an estimated 1.03 quarters of funding. Management is relying on incoming customer receipts, an R&D tax refund and a new A$5 million invoice financing facility to support the rollout.
Sophie Babbage
Sophie Babbage
30 Oct 2026
New Age Exploration has logged more than 100 metres of alteration, veining and sulphides at its Wallah Silver Project, but laboratory assays are still needed to establish whether the zone contains silver mineralisation. At Lammerlaw, a standout gold hole is driving a larger 2027 trenching and drilling campaign while cash of $728,000 covers only 0.87 quarters of reported outgoings.
Maxwell Dee
Maxwell Dee
30 Oct 2026
GenusPlus has completed its acquisition of New Zealand telecommunications contractor UCG, extending the group’s communications infrastructure footprint into New Zealand and the Pacific Islands. The upfront consideration was funded from existing cash reserves and a debt facility, but the company has not disclosed the purchase price or expected earnings contribution.
Victor Sage
Victor Sage
30 Oct 2026
Invex Therapeutics has paired its proposed acquisition of Rekover Therapeutics with a $10 million equity raising to fund a Phase 2a multiple sclerosis study and its existing Exenatide programs. The biotech ended September with A$3.59 million in cash, with shareholder approval still required for the larger part of the transaction.
Ada Torres
Ada Torres
30 Oct 2026
Recce Pharmaceuticals has cleared an active-comparator design for its pivotal Australian diabetic foot infection trial while an independent review of Indonesian Phase 3 data approaches. The biotech ended the quarter with A$1.04 million in cash, alongside expected tax rebates and unused financing facilities.
Victor Sage
Victor Sage
30 Oct 2026
Bathurst Resources lifted first-quarter consolidated EBITDA to NZ$9 million, helped by stronger export coal pricing and improved North Island domestic earnings. The miner held its FY27 EBITDA guidance at NZ$30 million to NZ$40 million while advancing two projects that could extend its operating life by up to 20 years.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Yandal Resources has locked in a $9 million placement and is seeking another $1 million from shareholders to accelerate drilling across its Western Australian gold projects. Gold Fields is expected to emerge with a 19.9% holding, while the raising will increase Yandal’s potential share count by roughly 35%.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Reece delivered 4.3% sales growth in the first quarter of FY27, powered by a 12.8% increase across Australia and New Zealand. The US remained subdued, while management flagged a cautious view of the second half.
Victor Sage
Victor Sage
30 Oct 2026
Pancontinental Energy has applied to extend its PEL 87 exploration rights in Namibia, backed by a proposed firm well and 4,200 square kilometres of seismic reprocessing. The company has also awarded DUG Technology the reprocessing contract, while its $1.866 million cash balance leaves future exploration funding as a key consideration.
Victor Sage
Victor Sage
30 Oct 2026

Browse the archive

Full archive